101 results
8-K
EX-2.1
NVRO
Nevro Corp
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
not own any capital stock of, or any other Equity Interest of, or any Equity Interest of any nature in, any other Person.
3.2 Authorization. All … of the Company or its internal accounting controls.
3.6 Undisclosed Liabilities. The Company does not have any material Liabilities of a nature required
S-1
EX-10.4
NVRO
Nevro Corp
3 Oct 14
IPO registration
12:00am
or proprietary in nature. Confidential Information shall also include all summaries, analyses, documents, memoranda, notes and other writings, including … such timely shipment of Products, CCC shall (i) immediately notify Nevro of the nature of the problem, the methods taken to overcome the problem
DRS/A
EX-10.4
NVRO
Nevro Corp
16 Sep 14
Draft registration statement (amended)
12:00am
or proprietary in nature. Confidential Information shall also include all summaries, analyses, documents, memoranda, notes and other writings, including … such timely shipment of Products, CCC shall (i) immediately notify Nevro of the nature of the problem, the methods taken to overcome the problem
CORRESP
NVRO
Nevro Corp
15 Oct 14
Correspondence with SEC
12:00am
. This Letter is accompanied by such request for confidential treatment because of the commercially sensitive nature of the information discussed … , the likelihood of completing the liquidity event is uncertain. The Hybrid Method considers a company’s going concern nature, stage of development
DRS/A
EX-10.4
NVRO
Nevro Corp
16 Sep 14
Draft registration statement (amended)
12:00am
, through its affiliated companies, distributors, resellers or agents of any type or nature or otherwise, develop, manufacture, market, distribute or sell
S-1
EX-10.4
n5h rr35v3bcwp0t1
3 Oct 14
IPO registration
12:00am
DRSLTR
miaflg82p06czii0os
16 Sep 14
Correspondence regarding draft registration statement
12:00am
S-1
EX-10.8
syvg1ghuqoknehnrv9zx
3 Oct 14
IPO registration
12:00am
D
92z zuhhw4y1eme501l
23 Apr 10
$21M in equity, sold $20M, 11 investors
12:00am
10-K
EX-10.23
nuj437a9g 3h0tuo
18 Mar 15
Annual report
12:00am
8-K
EX-10.1
p4tsjb2syftkbzdp7
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
S-1
EX-10.7
3xng19q
3 Oct 14
IPO registration
12:00am
S-1/A
EX-10.12
4d76lbf
10 Oct 14
IPO registration (amended)
12:00am